BioSpace News Archive

Global health services company Cigna Corporation announced that its Board of Directors has instituted a quarterly cash dividend and declared the first quarterly cash dividend of $1.00 per share of Cigna common stock to be paid on March 25, 2021 to shareholders of record as of the close of trading on March 10, 2021.

Owens & Minor, Inc. (NYSE: OMI) announced today that the company will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021.

Adeptrix Corp, the developer of advanced bioanalytical tools based on its proprietary BAMS™ (Bead Assisted Mass Spectrometry) platform technology, today announced the closing of its Series A investment round with Bruker Corporation as a new minority investor.

Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that management will participate in the H.C. Wainwright BioConnect Conference being held virtually from January 11-14, 2021. Corey Fishman, Chief Executive Offic

Peptomyc S.L., a biotech company specialized in the development of protein and peptide therapeutics targeting the Myc oncoprotein for cancer treatment, announces today that has appointed veteran pharma and biotech executive Giacomo Di Nepi as Chairman of the Board . Mr. Di Nepi has accumulated nearly 40 years of global experience in the Healthcare sector . His career started with 16 years at McKinsey & Company, where he was a Partne

The Government of Canada welcomes the Government of Ontario’s announcement to offer COVID-19 testing on-site at Toronto Pearson International Airport for arriving international travellers who wish to take a test prior to leaving the airport.

Harpoon Therapeutics, Inc., announced the pricing of an underwritten public offering of 5,882,352 shares of its common stock at a price to the public of $17.00 per share.

Walgreens Boots Alliance and VillageMD announced that WBA has accelerated its investment in VillageMD to support the opening of 600 to 700 Village Medical at Walgreens primary care clinics in more than 30 U.S.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to report it has enrolled and safely dosed the last patient for stage 2 of Part C of its TACTI-002 Phase II study.

MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR), a commercial-stage biopharmaceutical company and a leader in antibody, protein and peptide technologies, announced today the appointment of Sung Lee as Chief Financial Officer, effective February 2, 2021.